Member Info for Magsy18

Fair point. In the 5th May GDR RNS, it stated at least 60% gross margin for the covid test. I can’t actually find it in an NCYT RNS but as the gross margin for PrimerDesign for last 2 years has been approx 85%, people are assuming that minus distribution royalties that you are looking at at least 60%.

I never said they were exactly the same products so I will leave that point.

Do we know of any other of the covid stocks that have gone through CE Mark and FDA/WHO approval?

We know for NCYT, from CE marking, it took 5 weeks for FDA and 7 weeks for WHO.

Some other examples would help give a better idea on the realistic timescales.

Both companies stated the same predicted gross
margins in RNS’s. Which is all we have to go off.

You used the phrase ‘comparing apples and oranges’ which is used when you think the two things are not valid to compare.

Want to try again?

If people sold because they thought it was going to drop further then that’s a really risky move. It could well hit the low 140’s again prior to any sales but the moment a sales RNS hits, it’s unlikely these prices would be seen for a long time.

Are you seriously claiming that NCYT can’t be compared to us. Both companies are trying to do pretty much exactly the same. With the same price per test. With the same gross margin.

Ben, got the source that says they are barely breaking even? Useful comparison for us.

Doesn’t help when companies like NCYT post an additional £30m in sales and the share price drops 5%. I know not getting approval in France is unexpected for them but still, a surprising reaction.

Why the drop?

Yep their discussion board was very confident they would get sales in France. Another £30m not to be sniffed at though.

He is also the guy who gambled his child care money on shares.

Best. Dad. Ever.

He is hilariously clueless. Look at his comments on ODX.

Yesterday just before close ‘You don't want to be out in the morning!’

This morning ODX drops, ‘What’s going on?’

Market hasn’t reacted well to their RNS so far. Looks like a bit of sell on news plus failure to get approval in France.

When first sales contract comes in.

NCYT already have FDA approval so not sure why you’re saying they won’t get it. Took approx 5 weeks after CE Mark.

No one knows when they will finish, no one knows whether the price will go down from here.

If you are happy with the price when your funds clear then buy and if not, don’t.

Some rampers were talking about NHS contracts news today, remember their names, ignore them.

Sales are expected sometime in June.

No I don’t but the market isn’t convinced.

Strongboes, can you give your view on this scenario please?

Let’s say that all the ‘big sellers’ move out the way, that we get approvals for every country in the world, that we get interviews on all the major news outlets but we don’t end up getting any sales? What do you think would happen to the share price?

So my opinion on why it hasn’t risen is nonsense but your’s isn’t.

Of course.

Welcome to the behaviour of markets. The actions of people on this board will have no impact. Yes, in theory, if you could get a large proportion of the market to coordinate their behaviour then you could make something happen. In reality this isn’t going to happen.

The main reason this can be manipulated in any way is because there hasn’t been sufficient good news for enough people to care about.

Sales please.